Everything You Need to Know About the Record CSL Dividend
Everything You Need to Know About the Record CSL Dividend
It's been a bouncy but positive day for the $S&P/ASX 200 (.XJO.AU)$ and many ASX 200 shares this Tuesday. After starting the week off on a strong footing yesterday, the ASX 200 is continuing that momentum today, with the index currently up 0.05%. But let's talk about what's happening with $CSL Ltd (CSL.AU)$ shares.
对于他们来说，今天是充满活力但积极的一天 $S&P/ASX 200 (.XJO.AU)$ 本周二还有许多澳大利亚证券交易所200股股票。澳大利亚证券交易所200指数在昨天稳步开盘后，今天延续了这一势头，目前该指数上涨了0.05％。但是，让我们来谈谈发生了什么 $CSL Ltd (CSL.AU)$ 股份。
CSL shares are not faring as well as the broader market, to put it nicely. In fact, the ASX 200 healthcare giant is having an awful day.
说得好，CSL的股票表现不如整个市场。实际上，这家澳大利亚证券交易所200指数医疗巨头的日子过得很糟糕。
Yesterday, the CSL share price closed at $308.93. But this morning, those same shares opened at just $300.03 and are currently trading at $296.37. That's down a hefty 4.07% for the day thus far.
昨天，CSL的股价收于308.93美元。但是今天上午，同样的股票开盘价仅为300.03美元，目前的交易价格为296.37美元。到目前为止，这一数字已大幅下降了4.07％。
It seems investors are not too impressed with the full-year earnings report that the company dropped this morning.
该公司今天上午发布的全年收益报告似乎并没有给投资者留下太深刻的印象。
As we covered at the time, these earnings contained some fairly impressive figures. CSL reported an 11% bump in revenues for the 12 months to 30 June to US$14.8 billion.
正如我们当时所报道的那样，这些收益包含一些相当可观的数字。CSL报告称，在截至6月30日的12个月中，收入增长了11％，达到148亿美元。
That helped push the company's net profit after tax before amortisation (NPATA) up by 11% to US$2.91 billion, or up 15% to US$3.01 billion in constant currency terms.
这使该公司的摊销前税后净利润（NPATA）增长了11％，至29.1亿美元，按固定货币计算，增长了15％，至30.1亿美元。
As my Fool colleague covered after market open, it seems that investors may have been disappointed by CSL's guidance for FY2025. The company is expecting to record revenue growth of between 5-7% for the 12 months to 30 June 2025, and an NPATA of between US$3.2 and US$3.3 billion.
正如我的傻瓜同事在市场开盘后所报道的那样，投资者似乎对CSL的 FY2025 指导感到失望。该公司预计，在截至2025年6月30日的12个月中，收入将增长5-7％，NPATA将在32亿至33亿美元之间。
But let's talk about the supersized dividend that CSL has just revealed.
但是，让我们来谈谈CSL刚刚透露的超大规模股息。
CSL ups its dividend to new record high
CSL将其股息提高至历史新高
This morning, CSL revealed that its final dividend for FY2024 would come in at US$1.45 per share. That's a healthy 12.4% rise over the final dividend of US$1.29 ($2.01) per share that investors received last year, as well as a 21.85% increase over April's interim dividend of US$1.19 ($1.80) per share.
今天上午，CSL透露，其 FY2024 的末期股息将为每股1.45美元。这比去年投资者获得的每股1.29美元（合2.01美元）的末期股息增长了12.4％，也比4月份每股1.19美元（1.80美元）的中期股息增长了21.85％。
We don't yet know whether this latest payment will be in Australian dollars, but at today's exchange rates, US$1.45 would equate to approximately $2.20 per share. Like April's interim dividend, it will not come with any franking credits attached.
我们还不知道最新一笔款项是否将以澳元支付，但按照今天的汇率，1.45美元相当于每股约2.20美元。与4月份的中期股息一样，它不会附带任何邮费抵免额。
Nevertheless, this is a big deal for CSL, as this latest dividend represents a record-high shareholder payout for the company.
尽管如此，这对CSL来说是一件大事，因为最新的股息代表了该公司创纪录的股东派息。
However, shareholders will have to wait a while until this passive income arrives in their bank accounts. CSL has scheduled Monday, 9 September next month as this payment's ex-dividend date. So anyone wishing to bag this payout will have to own CSL shares by market close on Friday, 6 September.
但是，股东将不得不等待一段时间，直到这笔被动收入进入他们的银行账户。CSL已将下个月9月9日星期一定为这笔款项的除息日。因此，任何希望获得这笔款项的人都必须在9月6日星期五收盘前拥有CSL的股票。
The payment date will then roll around on 2 October.
然后，付款日期将延至10月2日。
CSL's dividend reinvestment plan (DRP) is not operating for this payment, so shareholders have no other option than to receive a traditional cash payment.
CSL的股息再投资计划（DRP）不适用于这笔付款，因此股东别无选择，只能获得传统的现金支付。
At today's pricing, CSL shares have a trailing dividend yield of 1.28%. If we factor in the newly announced dividend, CSL would have a forward dividend yield of 1.35%.
按今天的定价计算，CSL股票的尾随股息收益率为1.28％。如果将新宣布的股息考虑在内，CSL的远期股息收益率将为1.35％。